EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 11, 2006, Pages 1374-1380

  Vander Borght, T ^a   Asenbaum, S ^b   Bartenstein, P ^c   Halldin, C ^d   Kapucu, O ^e   Van Laere, K ^f   Varrone, A ^g   Tatsch, K ^h  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d KAROLINSKA INSTITUTE   (Sweden)

^e GAZI UNIVERSITY   (Turkey)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g CNR   (Italy)

^h UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; FLUORINE 18; IODINE 123; METHIONINE C 11; RADIOPHARMACEUTICAL AGENT; TYROSINE;

BLOOD BRAIN BARRIER; BRAIN TUMOR; HUMAN; ISOTOPE LABELING; MEDICAL ERROR; MEDICAL INFORMATION; MEDICAL PRACTICE; MEDICAL SOCIETY; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RADIATION DOSE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING; TUMOR BIOPSY; TUMOR DIAGNOSIS;

AMINO ACIDS; BRAIN NEOPLASMS; EUROPE; NUCLEAR MEDICINE; PHYSICIAN'S PRACTICE PATTERNS; RADIOISOTOPES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 33750351328     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0206-3     Document Type: Review

References (19)

1. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001;42:432-45
2. 123I]Iodo-α-methyl- Ltyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 2002;29:631
3. Laverman P, Boerman OC, Corstens FH, Oyen WJ. Fluorinated amino acids for tumour imaging with positron emission tomography. Eur J Nucl Med Mol Imaging 2002;29:681-690
4. 11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res 2004;10:7163-7170
5. 18F]fluoroethy)- L-tyrosine. Eur J Nucl Med Mol Imaging 2003;30:519-524
6. 123C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med 2004;45:1293-1298
7. Riemann B, Papke K, Hoess N, Kuwert T, Weckesser M, Matheja P, et al. Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT. Radiology 2002;225:567-574
8. 11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 2003;30:868-873
9. De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, et al. Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 2001;95:746-750
10. Levivier M, Massager N, Wikler D, Lorenzoni J, Ruiz S, Devriendt D, et al. Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification. J Nucl Med 2004;45:1146-1154
11. 123I-iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study. J Nucl Med 2002;43:1201-1206
12. 11C] methionine using whole-body positron emission tomography. Eur J Nucl Med 1998;25:629-633
13. 123I-iodo-alpha- methyltyrosine. Eur J Nucl Med 1997;24:1162-1166
14. Kuwert T, Morgenroth C, Woesler B, Matheja P, Palkovic S, Vollet B, et al. Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions. Eur J Nucl Med 1996;23:1345-1353
15. Kuwert T, Woesler B, Morgenroth C, Lerch H, Schafers M, Palkovic S, et al. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine. J Nucl Med 1998;39:23-27
16. 123I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas. J Nucl Med 2001;42:1144-1150
17. 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging 2005;32:39-51
18. 18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 2005;128:678-687
19. Cook GJ, Maisey MN, Fogelman I. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med 1999;26:1363-1378